Science Explorer Back to mapMap
Discussion

Lexicon Pharmaceuticals (United States)

In research, Lexicon Pharmaceuticals (United States) stands highest in Life Sciences (#7,113 of 11,023 worldwide), Health Sciences (#12,331 of 16,688 worldwide) and Medicine (#10,872 of 14,558 worldwide), over all time.

World rank, 2022-now
#19,689
of 22,385 · #16,699 all time
Rank in United States
#2,914
of 3,332
Research works
565
▼ 27% vs 2018-21
Citations
18k
31.3 per fractional work
Top-10% rate
5.6%
all institutions 10.0%
vs its own fields
0.97×
1.00× is exactly expected
Open access
50%
world 40%
International
20%
world 18%

What is Lexicon Pharmaceuticals (United States) known for in research?

The fields where it stands highest, over all time, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorks
Life SciencesDomain #7,113 of 11,023 14.2%142
Health SciencesDomain #12,331 of 16,688 16.1%137
MedicineField #10,872 of 14,558 16.9%124
Social SciencesDomain #13,263 of 14,833 10.0%145
Physical SciencesDomain #17,086 of 17,446 5.8%141

Each strip is that field's whole ranked pool, with the notch where Lexicon Pharmaceuticals (United States) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no average mark, because the average differs by field (from about 6% in Dentistry to 21% in Economics).

Which fields of science does Lexicon Pharmaceuticals (United States) work in?

In 2022-now, 43% of research at Lexicon Pharmaceuticals (United States) is in Social Sciences, 25% in Health Sciences. Its largest fields are Medicine (23%), Social Sciences (20%), Computer Science (18%). It does 1.7× the world's share of Social Sciences.

Social Sciences: 44 fractional works · 43.3% of its workSocial Sciences: 20 fractional works · 19.8% of its workPolitical Science and International Relations: 5 fractional works · 5.0% of its workSafety Research: 5 fractional works · 4.8% of its workSociology and Political Science: 3 fractional works · 2.6% of its workEducation: 3 fractional works · 2.5% of its workLaw: 2 fractional works · 2.1% of its workGeneral Social Sciences: 1 fractional works · 0.7% of its workCommunication: 1 fractional works · 0.6% of its workCultural Studies: 0 fractional works · 0.5% of its workAnthropology: 0 fractional works · 0.4% of its workHealth: 0 fractional works · 0.3% of its workDemography: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.1% of its workArts and Humanities: 13 fractional works · 12.5% of its workLanguage and Linguistics: 9 fractional works · 8.9% of its workPhilosophy: 1 fractional works · 1.2% of its workLiterature and Literary Theory: 1 fractional works · 1.1% of its workGeneral Arts and Humanities: 1 fractional works · 1.0% of its workSmaller subfields together: 0 fractional works · 0.3% of its workBusiness, Management and Accounting: 4 fractional works · 4.0% of its workOrganizational Behavior and Human Resource Management: 1 fractional works · 1.2% of its workAccounting: 1 fractional works · 1.0% of its workStrategy and Management: 1 fractional works · 0.8% of its workManagement of Technology and Innovation: 0 fractional works · 0.5% of its workMarketing: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.2% of its workEconomics, Econometrics and Finance: 4 fractional works · 3.9% of its workEconomics and Econometrics: 3 fractional works · 2.8% of its workFinance: 1 fractional works · 1.0% of its workSmaller subfields together: 0 fractional works · 0.1% of its workPsychology: 3 fractional works · 2.8% of its workDevelopmental and Educational Psychology: 1 fractional works · 1.2% of its workExperimental and Cognitive Psychology: 1 fractional works · 0.8% of its workSocial Psychology: 1 fractional works · 0.8% of its workSmaller subfields together: 0 fractional works · 0.1% of its workDecision Sciences: 0 fractional works · 0.3% of its workInformation Systems and Management: 0 fractional works · 0.3% of its workHealth Sciences: 25 fractional works · 24.8% of its workMedicine: 24 fractional works · 23.5% of its workEndocrinology, Diabetes and Metabolism: 7 fractional works · 7.3% of its workCardiology and Cardiovascular Medicine: 4 fractional works · 3.6% of its workPhysiology: 2 fractional works · 1.9% of its workPublic Health, Environmental and Occupational Health: 1 fractional works · 1.4% of its workSurgery: 1 fractional works · 1.4% of its workEpidemiology: 1 fractional works · 1.2% of its workHealth Informatics: 1 fractional works · 1.2% of its workNephrology: 1 fractional works · 0.8% of its workNeurology: 1 fractional works · 0.7% of its workOphthalmology: 1 fractional works · 0.7% of its workRadiology, Nuclear Medicine and Imaging: 1 fractional works · 0.6% of its workPharmacology: 1 fractional works · 0.6% of its workPsychiatry and Mental health: 0 fractional works · 0.5% of its workFamily Practice: 0 fractional works · 0.4% of its workGenetics: 0 fractional works · 0.3% of its workSmaller subfields together: 1 fractional works · 1.0% of its workHealth Professions: 1 fractional works · 0.9% of its workGeneral Health Professions: 0 fractional works · 0.4% of its workHealth Information Management: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.2% of its workNursing: 0 fractional works · 0.5% of its workNutrition and Dietetics: 0 fractional works · 0.5% of its workPhysical Sciences: 23 fractional works · 22.4% of its workComputer Science: 19 fractional works · 18.4% of its workArtificial Intelligence: 12 fractional works · 11.4% of its workSignal Processing: 2 fractional works · 1.8% of its workInformation Systems: 2 fractional works · 1.8% of its workComputer Vision and Pattern Recognition: 2 fractional works · 1.7% of its workComputer Networks and Communications: 1 fractional works · 0.7% of its workComputational Theory and Mathematics: 0 fractional works · 0.5% of its workHuman-Computer Interaction: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.2% of its workEngineering: 3 fractional works · 2.6% of its workControl and Systems Engineering: 1 fractional works · 0.7% of its workElectrical and Electronic Engineering: 1 fractional works · 0.7% of its workCivil and Structural Engineering: 1 fractional works · 0.7% of its workSmaller subfields together: 1 fractional works · 0.5% of its workEnvironmental Science: 1 fractional works · 0.6% of its workManagement, Monitoring, Policy and Law: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.3% of its workPhysics and Astronomy: 0 fractional works · 0.3% of its workStatistical and Nonlinear Physics: 0 fractional works · 0.3% of its workChemistry: 0 fractional works · 0.2% of its workMaterials Science: 0 fractional works · 0.1% of its workMathematics: 0 fractional works · 0.1% of its workEarth and Planetary Sciences: 0 fractional works · 0.1% of its workLife Sciences: 10 fractional works · 9.4% of its workBiochemistry, Genetics and Molecular Biology: 6 fractional works · 5.9% of its workMolecular Biology: 4 fractional works · 3.6% of its workCell Biology: 1 fractional works · 0.9% of its workGenetics: 1 fractional works · 0.7% of its workPhysiology: 0 fractional works · 0.3% of its workAging: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.1% of its workNeuroscience: 2 fractional works · 2.4% of its workCognitive Neuroscience: 1 fractional works · 1.4% of its workCellular and Molecular Neuroscience: 0 fractional works · 0.5% of its workEndocrine and Autonomic Systems: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.1% of its workAgricultural and Biological Sciences: 1 fractional works · 1.0% of its workFood Science: 1 fractional works · 0.7% of its workPlant Science: 0 fractional works · 0.3% of its workPharmacology, Toxicology and Pharmaceutics: 0 fractional works · 0.1% of its workImmunology and Microbiology: 0 fractional works · 0.0% of its workALL ITS WORKLexiconPharmaceuticals…101fractional works, 2022-now
Life Sciences9%Physical Sciences22%Health Sciences25%Social Sciences43%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 22 fields, with their numbers
    1. Social Sciences2019.8%
    2. Arts and Humanities1312.5%
    3. Business, Management and Accounting44.0%
    4. Economics, Econometrics and Finance43.9%
    5. Psychology32.8%
    6. Decision Sciences00.3%
    1. Medicine2423.5%
    2. Health Professions10.9%
    3. Nursing00.5%
    1. Computer Science1918.4%
    2. Engineering32.6%
    3. Environmental Science10.6%
    4. Physics and Astronomy00.3%
    5. Chemistry00.2%
    6. Materials Science00.1%
    7. Mathematics00.1%
    8. Earth and Planetary Sciences00.1%
    1. Biochemistry, Genetics and Molecular Biology65.9%
    2. Neuroscience22.4%
    3. Agricultural and Biological Sciences11.0%
    4. Pharmacology, Toxicology and Pharmaceutics00.1%
    5. Immunology and Microbiology00.0%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.20× its world share, 1 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 1.10× its world share, 6 worksBiochemistry, Geneti…Immunology and Microbiology: 0.05× its world share, 0 worksImmunology and Micro…Neuroscience: 1.51× its world share, 2 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 0.37× its world share, 0 worksPharmacology, Toxico…Chemistry: 0.11× its world share, 0 worksChemistryComputer Science: 2.36× its world share, 18 worksComputer ScienceEarth and Planetary Sciences: 0.04× its world share, 0 worksEarth and Planetary …Engineering: 0.17× its world share, 3 worksEngineeringEnvironmental Science: 0.12× its world share, 1 worksEnvironmental ScienceMaterials Science: 0.04× its world share, 0 worksMaterials ScienceMathematics: 0.11× its world share, 0 worksMathematicsPhysics and Astronomy: 0.15× its world share, 0 worksPhysics and AstronomyHealth Professions: 0.33× its world share, 1 worksHealth ProfessionsMedicine: 1.22× its world share, 24 worksMedicineNursing: 1.01× its world share, 0 worksNursingArts and Humanities: 4.33× its world share, 13 worksArts and HumanitiesBusiness, Management and Accounting: 1.23× its world share, 4 worksBusiness, Management…Decision Sciences: 0.28× its world share, 0 worksDecision SciencesEconomics, Econometrics and Finance: 1.84× its world share, 4 worksEconomics, Econometr…Psychology: 0.93× its world share, 3 worksPsychologySocial Sciences: 1.56× its world share, 20 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Arts and Humanities, 4.3×. Every wedge is a field page.

All 22 fields, with their numbers
  1. Arts and Humanities4.33×13 works
  2. Computer Science2.36×18 works
  3. Economics, Econometrics and Finance1.84×4 works
  4. Social Sciences1.56×20 works
  5. Neuroscience1.51×2 works
  6. Business, Management and Accounting1.23×4 works
  7. Medicine1.22×24 works
  8. Biochemistry, Genetics and Molecular Biology1.10×6 works
  9. Nursing1.01×0 works
  10. Psychology0.93×3 works
  11. Pharmacology, Toxicology and Pharmaceutics0.37×0 works
  12. Health Professions0.33×1 works
  13. Decision Sciences0.28×0 works
  14. Agricultural and Biological Sciences0.20×1 works
  15. Engineering0.17×3 works
  16. Physics and Astronomy0.15×0 works
  17. Environmental Science0.12×1 works
  18. Chemistry0.11×0 works
  19. Mathematics0.11×0 works
  20. Immunology and Microbiology0.05×0 works
  21. Earth and Planetary Sciences0.04×0 works
  22. Materials Science0.04×0 works

Who are the top researchers at Lexicon Pharmaceuticals (United States)?

Ranked on the quality score, Brian Zambrowicz, Arthur Sands and Phillip Lee Banks lead among researchers whose main affiliation is Lexicon Pharmaceuticals (United States).

  1. 1 Brian Zambrowicz United States · #35,149 worldwide 14k citations · 144 works
  2. 2 Arthur Sands United States · #115,650 worldwide 9.6k citations · 86 works
  3. 3 Phillip Lee Banks United States · #172,189 worldwide 4.1k citations · 106 works
  4. 4 David R. Powell United States · #187,650 worldwide 4k citations · 53 works
  5. 5 Brian D. Hamman United States · #284,898 worldwide 4.1k citations · 39 works
  6. 6 Kenneth A. Platt United States · #328,860 worldwide 6.3k citations · 46 works
  7. 7 Dennis S. Rice United States · #457,579 worldwide 6.7k citations · 85 works
  8. 8 Robert Brommage United States · #523,707 worldwide 5.9k citations · 117 works
  9. 9 Gwenn M. Hansen United States · #581,079 worldwide 3.1k citations · 65 works
  10. 10 Pablo Lapuerta United States · #654,055 worldwide 11k citations · 201 works
All ranked researchers at Lexicon Pharmaceuticals (United States)

What are the most cited papers from Lexicon Pharmaceuticals (United States)?

The most cited paper from Lexicon Pharmaceuticals (United States) is "Deep learning applications and challenges in big data analytics" (Maryam Mousaarab Najafabadi, Flavio Villanustre, Taghi M. Khoshgoftaar et al., 2015), with 2,613 citations. Next come "The Sketch Engine" (2,106) and "Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure" (1,872).

Most cited papers
#PaperReleasedCitations
1 Deep learning applications and challenges in big data analytics Maryam Mousaarab Najafabadi, Flavio Villanustre, Taghi M. Khoshgoftaar et al. · Journal Of Big Data Open access 23 Feb 2015 2,613
2 The Sketch Engine Adam Kilgarriff, Vít Baisa, Jan Bušta et al. · Lexicography Open access Jul 2014 2,106
3 Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure Deepak L. Bhatt, Michael J. Szarek, Philippe Gabríel Steg et al. · New England Journal of Medicine Open access 16 Nov 2020 1,872
4 Inhibition of Ceramide Synthesis Ameliorates Glucocorticoid-, Saturated-Fat-, and Obesity-Induced Insulin Resistance William L. Holland, Joseph T. Brozinick, Liping Wang et al. · Cell Metabolism Open access Mar 2007 1,231
5 Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease Deepak L. Bhatt, Michael J. Szarek, Bertram Pitt et al. · New England Journal of Medicine Open access 16 Nov 2020 1,206
All 60 most cited papers, with filters and sorting

Which keywords describe research at Lexicon Pharmaceuticals (United States)?

By fractional works in 2022-now, weighted toward what it does more of than the world: Artificial Intelligence, Heart Failure, Big Data, Machine Learning, Glycemic Control, Insulin Therapy, Ethics and Neural Networks.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Machine Learning11▲ 3.3×15 topics
  2. Artificial Intelligence10▲ 6.7×9 topics
  3. Big Data8▲ 7.8×8 topics
  4. Heart Failure8▲ 17×7 topics
  5. Glycemic Control7▲ 43×3 topics
  6. Insulin Therapy7▲ 54×3 topics
  7. Neural Networks7▲ 4.4×11 topics
  8. Deep Learning6▲ 1.73×15 topics
  9. Ethics6▲ 11×6 topics
  10. Type 2 Diabetes5▲ 23×3 topics
  11. Cardiovascular Outcomes5▲ 87×1 topic
  12. Glucose Control5▲ 87×1 topic
  13. Lexicography5▲ 57×3 topics
  14. Surveillance5▲ 16×2 topics
  15. Fairness4▲ 42×2 topics
  16. Algorithmic Bias4▲ 50×1 topic
  17. Transparency4▲ 30×1 topic
  18. Language4▲ 17×5 topics
  19. Corpus Linguistics4▲ 19×4 topics
  20. Cardiovascular Disease4▲ 3.2×9 topics
  21. Dictionaries3▲ 109×2 topics
  22. History3▲ 4.4×3 topics
  23. Language Teaching3▲ 11×4 topics
  24. Bilingualism3▲ 21×4 topics
  25. Electronic3▲ 162×1 topic
  26. Usage3▲ 162×1 topic
  27. Knowledge Representation3▲ 32×4 topics
  28. Sociolinguistics3▲ 15×5 topics
  29. Diabetes3▲ 5.2×8 topics
  30. International Law3▲ 8.4×6 topics
  31. Pragmatics3▲ 17×3 topics
  32. Ontologies2▲ 41×2 topics
  33. Specialized Language2▲ 123×1 topic
  34. Terminology2▲ 100×1 topic
  35. Ethical Implications2▲ 39×2 topics
  36. Language Contact2▲ 22×3 topics
  37. Phraseology2▲ 28×3 topics
  38. Language Variation2▲ 34×3 topics
  39. Text Classification2▲ 12×2 topics
  40. Topic Modeling2▲ 12×2 topics

Which research topics does Lexicon Pharmaceuticals (United States) publish most on?

By volume in 2022-now: Diabetes Treatment and Management, Ethics and Social Impacts of AI, Lexicography and Language Studies and linguistics and terminology studies.

  1. 1 Diabetes Treatment and Management Endocrinology, Diabetes and Metabolism 5 works
  2. 2 Ethics and Social Impacts of AI Safety Research 4 works
  3. 3 Lexicography and Language Studies Language and Linguistics 3 works
  4. 4 linguistics and terminology studies Language and Linguistics 2 works
  5. 5 Topic Modeling Artificial Intelligence 2 works
  6. 6 Adversarial Robustness in Machine Learning Artificial Intelligence 2 works
  7. 7 Spanish Linguistics and Language Studies Language and Linguistics 2 works
  8. 8 Cybersecurity and Cyber Warfare Studies Political Science and International Relations 2 works
  9. 9 Natural Language Processing Techniques Artificial Intelligence 2 works
  10. 10 Speech and Audio Processing Signal Processing 1 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available49.8%not open50.2%

World: 40% of research is openly available.

with international co-authors19.7%domestic only80.3%

World: 18% is written across borders.

How has Lexicon Pharmaceuticals (United States)'s research output changed?

Output in 2022-2025 was 27% lower than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Lexicon Pharmaceuticals (United States) as a percentage of every work published that year, 0.00034% in 2024.

still counting0.00050%0.0010%0.0015%Lexicon Pharmaceuticals (United States)0.00030% in 202519801990200020102020

Fractional works of Lexicon Pharmaceuticals (United States) over all fractional works that year. How the balance of science has shifted.

How much of it reaches the world top 10%

Year by year, against all institutions in the same year.

still counting5%10%15%all institutions10.0% in 2020Lexicon Pharmaceuticals (United States)0.9% in 202020102020

Of each year's output, the share that reached the world's 10% most cited for its field and year. Peak 14.9% in 2010.

Other research institutions in The Woodlands

All research institutions in The Woodlands

Share Lexicon Pharmaceuticals (United States)'s ranking

Lexicon Pharmaceuticals (United States) on Science Explorer

A card with Lexicon Pharmaceuticals (United States)'s standing and the fields it leads in, for a post or a slide. A link to this page previews as the same card.

Download the card

1200 × 630 PNG, sized for social posts, drawn from the latest snapshot.

Badges for a website1Each links back here and updates with every snapshot

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Lexicon Pharmaceuticals (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.